3.0.0 237 2025-12-05T09:07:45Z 2025-12-05T09:07:45Z Senate S S 2023-02-02 118 https://www.congress.gov/bill/118th-congress/senate-bill/237 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred To 2023-02-02T17:18:37Z 118 767 HR 2023-02-10 Referred to the Subcommittee on Health. Identical bill CRS 2023-02-02 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2023-02-02 Introduced in Senate IntroReferral 10000 9 Library of Congress S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN N B001288 Sen. Booker, Cory A. [D-NJ] Cory Booker D NJ 2023-02-02 True G000555 Sen. Gillibrand, Kirsten E. [D-NY] Kirsten Gillibrand D NY E. 2023-02-02 True H000273 Sen. Hickenlooper, John W. [D-CO] John Hickenlooper D CO W. 2023-02-02 True K000384 Sen. Kaine, Tim [D-VA] Timothy Kaine D VA M. 2023-02-02 True K000383 Sen. King, Angus S., Jr. [I-ME] Angus King I ME S. 2023-02-02 True M001176 Sen. Merkley, Jeff [D-OR] Jeff Merkley D OR 2023-02-02 True P000145 Sen. Padilla, Alex [D-CA] Alex Padilla D CA 2023-02-02 True S001194 Sen. Schatz, Brian [D-HI] Brian Schatz D HI 2023-02-02 True S000770 Sen. Stabenow, Debbie [D-MI] Debbie Stabenow D MI 2023-02-02 True Health Abortion 2023-06-16T19:30:32Z Health care coverage and access 2023-06-16T19:30:32Z Health technology, devices, supplies 2023-06-16T19:30:32Z Prescription drugs 2023-06-16T19:30:32Z Health 2023-02-22T17:30:53Z

00 2023-02-02 Introduced in Senate 2023-06-08T12:41:39Z <p><b>Protecting Access to Medication Abortion Act of 2023</b></p> <p>This bill requires the Food and Drug Administration (FDA) to ensure that patients may receive mifepristone through prescriptions issued via telehealth and filled by mail. The FDA has approved mifepristone for medication abortions (i.e., a procedure in which prescription drugs are used to terminate a pregnancy).</p> <p>(Mifepristone is subject to a Risk Evaluation and Mitigation Strategy, which imposes various safety-related requirements. During the COVID-19 public health emergency, the FDA suspended enforcement of a requirement that the drug must be dispensed in person, a requirement in the strategy at the time. In January 2023, the FDA updated the strategy to remove the in-person dispensing requirement.)</p> <p>Under this bill, the FDA must ensure that the strategy for mifepristone (1) does not have an in-person dispensing requirement, (2) allows patients to access prescriptions for mifepristone via telehealth, and (3) authorizes all pharmacies certified to dispense mifepristone to patients to do so via mail. </p> <p> <p>

Display Title 45 2024-07-24T15:23:54Z Short Title(s) as Introduced 101 2024-05-24T13:42:41Z Introduced in Senate IS Official Title as Introduced 6 2023-02-17T03:28:44Z Introduced in Senate IS Introduced in Senate 2023-02-02T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s237is/xml/BILLS-118s237is.xml 2023-02-02 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.